{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260326860298/en/Open-Label-Outpatient-Switch-Study-Demonstrates-Symptom-Stability-During-Transition-from-Oral-Atypical-Antipsychotics-to-Cobenfy%E2%84%A2-xanomeline-and-trospium-chloride", "message": "News view counter 632040 successfully enlarged"}